Do you use the highest or most recent PSA for risk stratification for newly diagnosed prostate cancer?

For example, if 2 pre-biopsy PSAs are 23 and then 18, would you stratify as intermediate or high risk? If otherwise intermediate risk, would you treat with short or long-term ADT?

Answer from: Radiation Oncologist at Academic Institution

This happens on occasion and can be a dilemma. First, I would repeat the PSA and see if it is <20 or >20, and take that into account. I would also take into account the genomic score. This may help further clarify the patient's risk category. If the patient had a reason for the first elevated ...

Comments

Radiation Oncologist at Providence St Mary Cancer Center
Thanks for your reply and the advice to look for e...

Radiation Oncologist at Providence St Mary Cancer Center
This same scenario just happened to me again. This...

Please select the option that best describes you:

Do you use the highest or most recent PSA for risk stratification for newly diagnosed prostate cancer?

Related Questions